Announcement of groundbreaking partnership between Nitrogen Danmark ApS and DanClan Biotech
News: Nitrogen Danmark introduces revolutionary cryogenic technology in Europe
We are proud to announce our new strategic partnership with the Chinese biotech company DanClan Biotech. This collaboration brings advanced cryogenic storage technology to Europe, significantly improving the capacity, safety, and application of liquid nitrogen within the research and healthcare sectors.
Revolutionary technology
The exclusive agreement between Nitrogen Danmark and DanClan Biotech gives us the exclusive right to distribute DanClan's innovative cryogenic technologies and products in Denmark and Europe. This includes advanced storage tanks and intelligent monitoring systems that ensure precise, controlled, and safe storage of biological samples. The partnership marks a milestone in cryogenic storage and monitoring technologies that will be of great significance across multiple industries.
"With the technological development, we are seeing a significant increase in the use of liquid nitrogen across sectors," says Said Fakhri, Director and Partner at Nitrogen Danmark ApS. "From biobanks, hospitals, and research institutions to the food industry, nitrogen plays a decisive role. Our new collaboration enables us to deliver more advanced and competitive solutions to our customers."
Innovative monitoring systems
From our headquarters at Industriholmen in Hvidovre, we are able to develop innovative and reliable solutions that can optimise customers' operational efficiency. DanClan Biotech, based in Chengdu, China, is globally recognised for its pioneering cryogenic storage technologies and IoT solutions for Life Science. Together with DanClan, we aim to set new standards for storage technologies in Europe.
The goal of the collaboration with DanClan Biotech is to integrate advanced monitoring technologies and secure storage solutions that can set new standards for cryogenic storage in Europe. We also have a shared ambition to develop new cryogenic products by sharing knowledge and resources.
Benefits for multiple industries
This advanced technology will not only benefit biobanks and the healthcare sector, but also the food industry, biotech companies, and other sectors requiring reliable and safe storage at extremely low temperatures. By bringing this technology to Europe, we ensure that more industries can benefit from improved capacity and safety in their storage processes.
We look forward to sharing more updates about our exciting collaboration and how it will revolutionise cryogenic technology in Europe.
